11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes

Author： Morgan Stuart A Tomlinson Jeremy W

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.9, 2010-09, pp. : 1067-1076

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

11β-Hydroxysteroid dehydrogenase type 1 inhibitors as therapeutic agents

By Webster Scott Peter Pallin Thomas David

Expert Opinion on Therapeutic Patents, Vol. 17, Iss. 12, 2007-12 ,pp. : 1407-1422

Informa Healthcare

Access to resources Recommend Favorite

11&bgr;-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development

Current Medicinal Chemistry, Vol. 17, Iss. 5, 2010-02 ,pp. : 412-422

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors of 17&bgr;-Hydroxysteroid Dehydrogenase Type 1

Current Medicinal Chemistry, Vol. 15, Iss. 2, 2008-01 ,pp. : 137-150

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule 11&bgr;- Hydroxysteroid Dehydrogenase Type 1 Inhibitors

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 12, 2011-06 ,pp. : 1464-1475

Bentham Science Publishers

Access to resources Recommend Favorite

Development of 11&bgr; -HSD1 Inhibitors for the Treatment of Type 2 Diabetes

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 7, 2008-06 ,pp. : 702-710

Bentham Science Publishers

Access to resources Recommend Favorite